Toward in vivo-relevant hERG safety assessment and mitigation strategies based on relationships between non-equilibrium blocker binding, three-dimensional channel-blocker interactions, dynamic occupancy, dynamic exposure, and cellular arrhythmia
Open Access
- 4 November 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (11) , e0234946
Abstract
The human ether-a-go-go-related voltage-gated cardiac ion channel (commonly known as hERG) conducts the rapid outward repolarizing potassium current in cardiomyocytes (IKr). Inadvertent blockade of this channel by drug-like molecules represents a key challenge in pharmaceutical R&D due to frequent overlap between the structure-activity relationships of hERG and many primary targets. Building on our previous work, together with recent cryo-EM structures of hERG, we set about to better understand the energetic and structural basis of promiscuous blocker-hERG binding in the context of Biodynamics theory. We propose a two-step blocker binding process consisting of: Lastly, we highlight possible flaws in the current hERG safety index (SI), and propose an alternate in vivo-relevant strategy factoring in:Keywords
All Related Versions
This publication has 55 references indexed in Scilit:
- Simulation of the Undiseased Human Cardiac Ventricular Action Potential: Model Formulation and Experimental ValidationPLOS Computational Biology, 2011
- Trapping and dissociation of propafenone derivatives in HERG channelsBritish Journal of Pharmacology, 2010
- New hypotheses about the structure–function of proprotein convertase subtilisin/kexin type 9: Analysis of the epidermal growth factor‐like repeat A docking site using WaterMapProteins: Structure, Function, and Bioinformatics, 2010
- hERG in vitro interchange factors—development and verificationToxicology Mechanisms and Methods, 2009
- Pharmacokinetics of Hydroxychloroquine and Its Clinical Implications in Chemoprophylaxis against Malaria Caused byPlasmodium vivaxAntimicrobial Agents and Chemotherapy, 2009
- State dependent dissociation of HERG channel inhibitorsBritish Journal of Pharmacology, 2007
- Identification of the cyclic-nucleotide-binding domain as a conserved determinant of ion-channel cell-surface localizationJournal of Cell Science, 2005
- Long QT syndromes and torsade de pointesThe Lancet, 1999
- Blockade of cardiac sodium channels. Competition between the permeant ion and antiarrhythmic drugs.Journal of Clinical Investigation, 1992
- Immobilisation of gating charge by a substance that simulates inactivationNature, 1978